Clinical Trial Update: Open-Label,Singel Center Study of Alefacept in Patients With Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 open-label trial of Alefacept in patients with Atopic Dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Alefacept (Alefacept)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED